Fitch Solutions, an industry provider of credit and macro intelligence, has predicted that the naira would slide to as low as N1,993 per dollar in 2028 severely impacting the country’s pharmaceutical ...

The acquisition of global rights to NJO from Sanofi is expected to contribute positively to EBITDA from 2025 onwards. Recordati SpA (RICFY) reported a robust free cash flow of 434.3 million euros, up ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Check the time stamp on this data. Updated AI-Generated Signals for Sanofi (SNY) available here: SNY.

With numerous planned submissions underway for 2024, the new platform is setting a new standard for managing simultaneous ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Board of Directors recently welcomed five new members: Christine Helfenbein, David Milligan, Milton Nagel, Talli Oxnam and ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

As RSV season ramps up, the American Lung Association is partnering with Sanofi to help educate parents and expectant parents about the symptoms of RSV and the steps they can take to help prevent ...

Also last year, the FTC blocked Sanofi’s proposed acquisition of a drug in development for Pompe disease, a genetic condition ...